Hazem E. Hassan

1.5k total citations
60 papers, 1.1k citations indexed

About

Hazem E. Hassan is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Pharmacology. According to data from OpenAlex, Hazem E. Hassan has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pediatrics, Perinatology and Child Health, 15 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in Hazem E. Hassan's work include Pharmacological Effects and Toxicity Studies (14 papers), Drug Transport and Resistance Mechanisms (12 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Hazem E. Hassan is often cited by papers focused on Pharmacological Effects and Toxicity Studies (14 papers), Drug Transport and Resistance Mechanisms (12 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Hazem E. Hassan collaborates with scholars based in United States, Egypt and Syria. Hazem E. Hassan's co-authors include Natalie D. Eddington, Hongbing Wang, Andrew Coop, William D. Hedrich, Alan L. Myers, Insong J. Lee, Tamer E. Fandy, Inas A. Abdallah, Audra L. Stinchcomb and Dana C. Hammell and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Controlled Release.

In The Last Decade

Hazem E. Hassan

56 papers receiving 1.1k citations

Peers

Hazem E. Hassan
Charles Locke United States
Jeremiah D. Momper United States
Mark Gardner United States
Garth Rapeport United Kingdom
Bing Zhu United States
Keri Wellington New Zealand
Hazem E. Hassan
Citations per year, relative to Hazem E. Hassan Hazem E. Hassan (= 1×) peers Pooja Gupta

Countries citing papers authored by Hazem E. Hassan

Since Specialization
Citations

This map shows the geographic impact of Hazem E. Hassan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazem E. Hassan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazem E. Hassan more than expected).

Fields of papers citing papers by Hazem E. Hassan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hazem E. Hassan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazem E. Hassan. The network helps show where Hazem E. Hassan may publish in the future.

Co-authorship network of co-authors of Hazem E. Hassan

This figure shows the co-authorship network connecting the top 25 collaborators of Hazem E. Hassan. A scholar is included among the top collaborators of Hazem E. Hassan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hazem E. Hassan. Hazem E. Hassan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
DiMartino, Stephen J., Haitao Gao, Guillermo J. Valenzuela, et al.. (2025). Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hip. BMC Musculoskeletal Disorders. 26(1). 192–192. 1 indexed citations
3.
DiMartino, Stephen J., Thomas J. Schnitzer, Haitao Gao, et al.. (2024). A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip. SHILAP Revista de lepidopterología. 6(4). 100533–100533. 2 indexed citations
4.
Turner, K. C., et al.. (2024). Population Pharmacokinetics of Fasinumab in Healthy Volunteers and Patients With Pain Due to Osteoarthritis of the Knee or Hip. Clinical Pharmacology in Drug Development. 13(6). 621–630. 1 indexed citations
5.
Hammell, Dana C., et al.. (2023). In Vitro—In Vivo Correlation of Buprenorphine Transdermal Systems Under Normal and Elevated Skin Temperature. Pharmaceutical Research. 40(5). 1249–1258. 1 indexed citations
6.
Bunge, Annette L., et al.. (2022). Investigator Impact on Reproducibility of Drug Bioavailability in Stratum Corneum Sampling by Tape Stripping. Pharmaceutical Research. 39(4). 703–719.
7.
Hassan, Hazem E., et al.. (2022). Evaluation of Publicly Available Information on Sex-Related Differences in the Efficacy and Safety of Newly Approved Medications. Journal of General Internal Medicine. 37(11). 2894–2897.
8.
Hammell, Dana C., et al.. (2020). Effect of Controlled Heat Application on Topical Diclofenac Formulations Evaluated by In Vitro Permeation Tests (IVPT) Using Porcine and Human Skin. Pharmaceutical Research. 37(3). 49–49. 10 indexed citations
10.
Ibrahim, Sarah, et al.. (2018). The Sensitivity of In Vitro Permeation Tests to Chemical Penetration Enhancer Concentration Changes in Fentanyl Transdermal Delivery Systems. AAPS PharmSciTech. 19(7). 2778–2786. 14 indexed citations
12.
Ghosh, Priyanka, Bryan Newman, Dana C. Hammell, et al.. (2017). On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl. Pharmaceutical Research. 34(9). 1817–1830. 22 indexed citations
13.
Hedrich, William D., Hazem E. Hassan, & Hongbing Wang. (2016). Insights into CYP2B6-mediated drug–drug interactions. Acta Pharmaceutica Sinica B. 6(5). 413–425. 106 indexed citations
14.
Gharavi, Robert, William D. Hedrich, Hongbing Wang, & Hazem E. Hassan. (2015). Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions. Pharmaceutical Research. 32(8). 2477–502. 17 indexed citations
15.
Fandy, Tamer E., Inas A. Abdallah, Maan T. Khayat, David A. Colby, & Hazem E. Hassan. (2015). In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine. Cancer Chemotherapy and Pharmacology. 77(2). 259–267. 24 indexed citations
16.
Hassan, Hazem E., et al.. (2014). Curcumin and Dimethoxycurcumin Induced Epigenetic Changes in Leukemia Cells. Pharmaceutical Research. 32(3). 863–875. 35 indexed citations
17.
Metcalf, Matthew, Hazem E. Hassan, Natalie D. Eddington, et al.. (2014). Opioids and efflux transporters. Part 4: Influence of N-substitution on P-glycoprotein substrate activity of noroxymorphone analogues. Bioorganic & Medicinal Chemistry Letters. 24(15). 3592–3595. 10 indexed citations
18.
Hassan, Hazem E., et al.. (2011). Effects of sertraline on the pharmacokinetics of bupropion and its major metabolite, hydroxybupropion, in mice. European Journal of Drug Metabolism and Pharmacokinetics. 37(1). 57–63. 9 indexed citations
19.
Hassan, Hazem E., Susan L. Mercer, Christopher W. Cunningham, Andrew Coop, & Natalie D. Eddington. (2009). Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: Comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions. International Journal of Pharmaceutics. 375(1-2). 48–54. 21 indexed citations
20.
Hassan, Hazem E., Alan L. Myers, Insong J. Lee, Andrew Coop, & Natalie D. Eddington. (2007). Oxycodone induces overexpression of P‐glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats. Journal of Pharmaceutical Sciences. 96(9). 2494–2506. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026